Business Description
Biora Therapeutics Inc
NAICS : 541714
SIC : 2833
ISIN : US74319F3055
Description
Financial Strength
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.32 | |||||
Equity-to-Asset | -3.25 | |||||
Debt-to-Equity | -0.47 | |||||
Debt-to-EBITDA | -0.42 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -56.35 | |||||
Beneish M-Score | 49.22 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 57.8 | |||||
3-Year EPS without NRI Growth Rate | 54.5 | |||||
3-Year FCF Growth Rate | 72.9 | |||||
3-Year Book Growth Rate | 57.6 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 46.22 | |||||
9-Day RSI | 35.82 | |||||
14-Day RSI | 35.34 | |||||
6-1 Month Momentum % | -32.14 | |||||
12-1 Month Momentum % | -42.42 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.3 | |||||
Quick Ratio | 0.3 | |||||
Cash Ratio | 0.24 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -131.9 | |||||
Shareholder Yield % | 59.97 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -1678575 | |||||
Net Margin % | -3102875 | |||||
FCF Margin % | -1215050 | |||||
ROA % | -279.09 | |||||
ROIC % | -166.55 | |||||
ROC (Joel Greenblatt) % | -3590.96 | |||||
ROCE % | -15131.9 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -0.48 | |||||
EV-to-Forward-EBIT | -0.73 | |||||
EV-to-EBITDA | -0.48 | |||||
EV-to-Forward-EBITDA | -0.73 | |||||
EV-to-Revenue | 13666.75 | |||||
EV-to-Forward-Revenue | 16.41 | |||||
EV-to-FCF | -1.12 | |||||
Earnings Yield (Greenblatt) % | -208.33 | |||||
FCF Yield % | -215.2 |